Company: CERO
Filing Date: 2025-08-15
Form Type: NT 10-Q
Source: 0001213900-25-077436
Chunk: 4

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-08-15
Form: NT 10-Q
Chunk 4
---
 discussed and identified in public filings made by the Company with the Securities
and Exchange Commission (the “SEC”) and the Company’s auditors being unable to complete their review of the quarterly
financial statements in a timely manner and the Company consequently not filing the Quarterly Report within the time period prescribed
in Rule 12b-25 promulgated under the Securities Exchange Act of 1934.

Any financial results discussed in this document
are preliminary and represent the most current information available to the Company’s management as of August 15, 2025, as financial
closing procedures for the quarter year ended June 30, 2025 are not yet complete. These estimates are not a comprehensive statement of
the Company’s financial results for the quarter ended June 30, 2025, and actual results may differ materially from these estimates
as a result of the completion of quarter-end accounting procedures and adjustments, including the execution of the Company’s internal
control over financial reporting, the completion of the preparation of the Company’s financial statements and the subsequent occurrence
or identification of events prior to the filing of the consolidated condensed financial statements for the quarter ended June 30, 2025
in its Quarterly Report. In addition, any such statements regarding the Company’s financial performance are not necessarily indicative
of the Company’s financial performance that may be expected to occur for the quarter ended June 30, 2025, or for any future fiscal
period.

Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein. This list
is not exhaustive of the factors that may affect any of the Company’s forward-looking statements. Forward-looking statements are
statements about the future and are inherently uncertain, and actual achievements of the Company or other future events or conditions
may differ materially from those reflected in the forward-looking statements due to a variety of risks, uncertainties, and other factors,
including without limitation those discussed under Part I, Item 1A. “Risk Factors” contained in the Company’s most recent
Annual Report on Form 10-K, and Part II, Item 1A. “Risk Factors” contained in the Company’s subsequent Quarterly Reports
on Form 10-Q, as well as any amendments thereto.

The Company’s forward-looking statements
contained in this document are based on the beliefs, expectations, and opinions of management as of the date of this document. The Company
does not assume any obligation to update forward-looking statements if circumstances or